市場調査レポート
商品コード
1430514

欧州の機能ゲノミクス市場:分析と予測(2023年~2033年)

Europe Functional Genomics Market: Analysis and Forecast, 2023-2033

出版日: | 発行: BIS Research | ページ情報: 英文 67 Pages | 納期: 1~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
欧州の機能ゲノミクス市場:分析と予測(2023年~2033年)
出版日: 2024年02月22日
発行: BIS Research
ページ情報: 英文 67 Pages
納期: 1~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要
主要市場統計
予測期間 2023年~2033年
2023年の評価額 30億1,000万米ドル
2033年予測 106億9,000万米ドル
CAGR 13.52%

2023年の欧州の機能ゲノミクスの市場規模は30億1,000万米ドルとなりました。

同市場は2033年には106億9,000万米ドルに達し、予測期間の2023年~2033年年のCAGRは13.52%になると予測されています。機能ゲノミクス市場は、特に標的治療と精密医療の領域での応用拡大が主な推進力となって、成長する態勢を整えています。

欧州の機能ゲノミクス市場は、ゲノム研究の進展と個別化医療に対する需要の高まりによって著しい成長を遂げています。機能ゲノミクスは、生物学的機能を理解するために、遺伝子がどのように相互作用し、環境と相互作用するかを研究するものです。バイオテクノロジーとライフサイエンスにおける欧州の強力なプレゼンスと研究開発への多額の投資により、同地域では疾病メカニズムの解明と標的療法の開発を目的としたゲノム研究が急増しています。さらに、学術機関、バイオテクノロジー企業、政府機関の連携が技術革新を促進し、市場拡大を後押ししています。さらに、ハイスループットシーケンスや遺伝子編集技術の採用が増加していることも、機能的ゲノム市場をさらに後押ししています。欧州がゲノム研究をリードし続ける中、機能的ゲノム市場は継続的な成長を遂げ、ヘルスケアとバイオテクノロジーの進歩に有望な機会を提供しています。

当レポートでは、欧州の機能ゲノミクス市場について調査し、市場の概要とともに、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 市場

  • 製品の定義
  • 包含基準と除外基準
  • 市場範囲
  • 調査手法

第2章 市場概要

  • 機能ゲノミクスワークフロー分析
  • 将来性
  • 機能ゲノミクスの影響
    • 遺伝子治療
    • 創薬と開発
    • 遺伝子発現
    • 単一細胞解析

第3章 地域

  • 概要
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の地域

第4章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • QIAGEN
図表

List of Figures

  • Figure 1: Europe Functional Genomics Market, $Billion, 2023 and 2033
  • Figure 2: Biological Features of Functional Genomics Approaches
  • Figure 3: Share of Functional Genomics Market (by Region), 2022
  • Figure 4: Functional Genomics Market: Research Methodology
  • Figure 5: Primary Research Methodology
  • Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 7: Top-Down Approach (Segment-Wise Analysis)
  • Figure 8: Epigenomics Workflow
  • Figure 9: Transcriptomics Workflow
  • Figure 10: Proteomics Workflow
  • Figure 11: Metabolomics Workflow
  • Figure 12: Functional Genomics Market Snapshot (by Region)
  • Figure 13: Functional Genomics Market (by Region), $Billion, 2023-2033
  • Figure 14: Europe Functional Genomics Market, $Billion, 2022-2033
  • Figure 15: Europe Functional Genomics Market (by Country), $Billion, 2022-2033
  • Figure 16: Germany Functional Genomics Market, $Billion, 2022-2033
  • Figure 17: France Functional Genomics Market, $Billion, 2022-2033
  • Figure 18: U.K. Functional Genomics Market, $Billion, 2022-2033
  • Figure 19: Italy Functional Genomics Market, $Billion, 2022-2033
  • Figure 20: Spain Functional Genomics Market, $Billion, 2022-2033
  • Figure 21: Rest-of-Europe Functional Genomics Market, $Billion, 2022-2033
  • Figure 22: Functional Genomics Market, Total Number of Key Companies Profiled
  • Figure 23: F. Hoffmann-La Roche Ltd: Product Portfolio
  • Figure 24: F. Hoffmann-La Roche Ltd: Overall Financials, 2020-2022
  • Figure 25: F. Hoffmann-La Roche Ltd: Revenue (by Segment), 2020-2022
  • Figure 26: F. Hoffmann-La Roche Ltd: R&D Expenditure, 2020-2022
  • Figure 27: Merck KGaA: Product Portfolio
  • Figure 28: Merck KGaA: Overall Financials, $Million, 2020-2022
  • Figure 29: Merck KGaA: Revenue (by Segment), $Million, 2020-2022
  • Figure 30: Merck KGaA: Revenue (by Region), $Million, 2020-2022
  • Figure 31: Merck KGaA: R&D Expenditure, $Million, 2020-2022
  • Figure 32: QIAGEN.: Product Portfolio
  • Figure 33: QIAGEN: Overall Financials, $Million, 2019-2021
  • Figure 34: QIAGEN: Revenue (by Segment), $Million, 2019-2021
  • Figure 35: QIAGEN: Revenue (by Region), $Million, 2019-2021
  • Figure 36: QIAGEN N.V.: R&D Expenditure, $Million, 2019-2021

List of Tables

  • Table 1: Europe Functional Genomics Market: Impact Analysis
  • Table 2: Technological Trends in Functional Genomics Market
  • Table 3: Europe: Market Dynamics
目次
Product Code: BHP1880SS

The Europe Functional Genomics Market Expected to Reach $10.69 Billion by 2033

Introduction to Europe Functional Genomics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$3.01 Billion
2033 Forecast$10.69 Billion
CAGR13.52%

In 2023, the Europe functional genomics market was valued at $3.01 billion, and it is expected to reach $10.69 billion by 2033, growing at a CAGR of 13.52% during the forecast period 2023-2033. The functional genomics market is poised for growth, primarily propelled by its expanding applications, particularly in the realms of targeted therapy and precision medicine.

Market Introduction

The functional genomics market in Europe is experiencing notable growth driven by advancements in genomic research and rising demand for personalized medicine. Functional genomics involves studying how genes interact with each other and the environment to understand biological functions. With Europe's strong presence in biotechnology and life sciences, coupled with significant investments in research and development, the region is witnessing a surge in genomic studies aimed at unraveling disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, biotech companies, and government agencies are fostering innovation and driving market expansion. Additionally, increasing adoption of high-throughput sequencing and gene editing technologies further propels the functional genomics market. As Europe continues to lead in genomic research, the functional genomics market is poised for continued growth, offering promising opportunities for advancements in healthcare and biotechnology.

Market Segmentation:

Segmentation 1: by Country

  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The report considers functional genomics kits and assays-based companies. The industry is seeing constant development and product launches with new and innovative upgrades. Additionally, new discoveries of more efficient instruments and tools of functional genomics are increasing researchers' trust in functional genomics.

Growth/Marketing Strategy: The key components in Europe functional genomics are the kits and assays along with the instruments for sample analysis. The advancements in the overall functional genomics ecosystem are influencing the growth of this market.

Competitive Strategy: The key players in the Europe functional genomics market have been analyzed and profiled in the study, consisting of most product-based companies. Moreover, a detailed competitive benchmarking of the players operating in the Europe functional genomics market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on thorough secondary research, which includes analyzing company coverage, product portfolio, market penetration, and insights gathered from primary experts.

Some prominent names established in this market are:

  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • QIAGEN

Table of Contents

Executive Summary

1 Markets

  • 1.1 Product Definition
  • 1.2 Inclusion and Exclusion Criteria
  • 1.3 Market Scope
    • 1.3.1 Scope of the Study
    • 1.3.2 Key Questions Answered in the Report
  • 1.4 Research Methodology
    • 1.4.1 Functional Genomics Market: Research Methodology
    • 1.4.2 Data Sources
    • 1.4.3 Market Estimation Model
    • 1.4.4 Criteria for Company Profiling

2 Market Overview

  • 2.1 Functional Genomics Workflow Analysis
  • 2.2 Future Potential
  • 2.3 Impact of Functional Genomics
    • 2.3.1 Gene Therapy
    • 2.3.2 Drug Discovery and Development
    • 2.3.3 Gene Expression
    • 2.3.4 Single-Cell Analysis

3 Region

  • 3.1 Overview
  • 3.2 Europe
    • 3.2.1 Germany
    • 3.2.2 France
    • 3.2.3 U.K.
    • 3.2.4 Italy
    • 3.2.5 Spain
    • 3.2.6 Rest-of-Europe

4 Company Profiles

  • 4.1 Overview
  • 4.2 F. Hoffmann-La Roche Ltd
    • 4.2.1 Company Overview
    • 4.2.2 Role of F. Hoffmann-La Roche Ltd in the Functional Genomics Market
    • 4.2.3 Financials
    • 4.2.4 Key Insights about the Financial Health of the Company
    • 4.2.5 Recent Developments
    • 4.2.6 Analyst Perspective
  • 4.3 Merck KGaA
    • 4.3.1 Company Overview
    • 4.3.2 Role of Merck KGaA in the Functional Genomics Market
    • 4.3.3 Financials
    • 4.3.4 Key Insights about the Financial Health of the Company
    • 4.3.5 Analyst Perspective
  • 4.4 QIAGEN
    • 4.4.1 Company Overview
    • 4.4.2 Role of QIAGEN in the Functional Genomics Market
    • 4.4.3 Financials
    • 4.4.4 Key Insights about the Financial Health of the Company
    • 4.4.5 Recent Developments
    • 4.4.6 Analyst Perspective